Takeda takes step towards EU Entyvio extension
Drug Discovery | News | 0 Comment | 02 Apr, 2019
Takeda Pharmaceutical Company Limited announced that the European Medicines Agency (EMA) has accepted a Marketing Author...Read more
Standigm raises $11.5M in Series B Round
Drug Discovery | News | 0 Comment | 02 Apr, 2019
Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, announced it has r...Read more
Takeda, StrideBio to advance novel gene therapies for neuro diseases
Drug Discovery | News | 0 Comment | 01 Apr, 2019
StrideBio, Inc, a leading developer of novel adeno-associated viral (AAV) based gene therapies, recently announced the s...Read more
HitGen, Almirall to identify novel drug targets
Drug Discovery | News | 0 Comment | 26 Mar, 2019
HitGen has announced that the company has entered into a research collaboration with Almirall to identify novel small mo...Read more
BioInvent developes Anti-TNFR2 programme for cancer treatment
Drug Discovery | News | 0 Comment | 21 Mar, 2019
BioInvent International AB, focused on the discovery and development of novel and first-in-class immuno-regulatory antib...Read more
EC approves Roche’s MabThera for a rare autoimmune disease
Drug Discovery | News | 0 Comment | 19 Mar, 2019
Roche announced that the European Commission has approved MabThera® (rituximab) for the treatment of adults with mod...Read more
Ono Pharma, twoXAR announce drug discovery research collaboration
Drug Discovery | News | 0 Comment | 19 Mar, 2019
Ono Pharmaceutical Co., Ltd., a Japanese pharmaceutical research and development company, and twoXAR, Inc., a US based a...Read more
Janssen seeks USFDA nod for Darzalex to treat ASCT multiple myeloma
Drug Discovery | News | 0 Comment | 14 Mar, 2019
The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a supplemental Biologics Licen...Read more
FDA approves new nasal spray for treatment-resistant depression
Drug Discovery | News | 0 Comment | 06 Mar, 2019
The U.S. Food and Drug Administration has approved Spravato (esketamine) nasal spray, in conjunction with an oral antide...Read more
Glenmark announces presentation of New Subtype Analysis of GBR 830
Drug Discovery | News | 0 Comment | 04 Mar, 2019
Glenmark Pharmaceuticals has announced the presentation of a new post hoc analysis of data from a Phase 2a, proof-of-con...Read more
USFDA accepts Merck and Pfizer’s sBLA for Renal Cancer drug
Drug Discovery | News | 0 Comment | 12 Feb, 2019
Merck and Pfizer Inc. has announced that the US Food and Drug Administration (FDA) has accepted for Priority Review...Read more
Teva announces US launch of Vigabatrin
Drug Discovery | News | 0 Comment | 08 Feb, 2019
Teva Pharmaceutical Industries has announced the launch of a generic version of Sabril®1 (vigabatrin) tablets, ...Read more
Perrigo to launch its AB rated generic Zovirax cream
Drug Discovery | News | 0 Comment | 07 Feb, 2019
Perrigo Company plc has announced it has received final approval from the U.S. Food and Drug Administration for its AB r...Read more
BioLineRx gets Orphan Drug Designation for its pancreatic cancer drug
Drug Discovery | News | 0 Comment | 07 Feb, 2019
BioLineRx Ltd., an Israeli clinical-stage biopharmaceutical company focused on oncology, announced that the U.S. Food an...Read more
Reaction Biology Corporation buys ProQinase GmbH
Drug Discovery | News | 1 Comment | 05 Feb, 2019
Reaction Biology Corporation ("RBC") and ChinaEquity Group ("CEG") have announced the conclusion of a stock exchange tra...Read more
I-Mab, BCT to work on Arginine Depletion Therapy and Biomarker Study
Drug Discovery | News | 0 Comment | 04 Feb, 2019
I-Mab Biopharma (I-Mab), a China-based clinical stage biopharmaceutical company exclusively focused on the developm...Read more
FDA expands Lilly's ALIMTA Label
Drug Discovery | News | 0 Comment | 01 Feb, 2019
Eli Lilly and Companyhas announced that USFDA has granted approval for a new indication for ALIMTA® (pemetrexed...Read more
Neurocrine Biosciences collaborates with Voyager Therapeutics
Drug Discovery | News | 0 Comment | 31 Jan, 2019
Neurocrine Biosciences and Voyager Therapeutics has announced the formation of a strategic collaboration focused on the ...Read more